Delivery Order SPE2DB20D3101-SPE2DB23FRKT3
Award Date
5/5/23
Potential Completion Date
5/8/23
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,422.00 Firm Fixed Price Delivery Order is for the supply of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product. The contract has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,906.49 firm-fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product, with an ultimate completion date of December 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,513.00 firm fixed-price delivery order covers the supply of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a specialty pharmaceutical product. The contract has a completion date of June 27, 2023 and is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a medical product, with a ceiling value of $1,147.37 and a performance period through May 15, 2024. The contract is a firm fixed-price delivery order, with no set-aside requirements indicated. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,197.84 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product, with a period of performance through October 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of OMNIPAQUE 300 MG/ML PLUSPAK 500ML medical products, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,643.86 firm fixed-price delivery order contract has a completion date of December 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.80 firm fixed-price delivery order is for OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product, with a period of performance through April 2025. The contract is not associated with a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with a value of $1,726.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product. The contract has a period of performance through June 25, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation, indicating the contract was competed openly....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,003.30 firm fixed-price delivery order is for the supply of OMNIPAQUE 180 MG/ML VIAL 10ML, a medical product used in healthcare settings. The contract has an ultimate completion date of March 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,769.38 firm fixed-price delivery order is for the supply of OMNIPAQUE 300 MG/ML PLUSPAK 500ML, a pharmaceutical product, with a period of performance through October 2024. This contract is not designated as a set-aside and represents an open competition award. Amerisourcebergen holds a significant $999,999,999...